UK female infertility diagnosis and treatment market is expected to witness a significant growth with the CAGR of 4.1% during the forecast period. UK is one of the major economies of Europe and a significant market for female infertility diagnosis and treatment will be observed in the region during the forecast period. The major factors driving the market growth include increasing infertility among women, well-developed healthcare infrastructure, and the presence of most of the major pharmaceutical market players.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/uk-female-infertility-diagnosis-and-treatment-market
UK female infertility diagnosis and treatment market is segmented on the basis of diagnosis, treatment type, and end-user. Based on the diagnosis, the market is segmented into ovulation testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (laparoscopy). Based on the treatment type, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART). Based on the end-user, the market is segmented into hospitals and clinics, homecare, and pathology and diagnostic center.
Some of the major players operating in UK female infertility diagnosis and treatment market include Abbott Laboratories, Inc., Merck KGaA, Cipla Ltd., and others. These players adopt various organic and inorganic growth strategies such as merger and acquisition and product launch to strengthen their presence in UK market.
Market Segmentation:
By Diagnosis
- Ovulation Testing
- Hysterosalpingography (HSG)
- Hysteroscopy
- Imaging Testing
- Ovarian Reserve Testing
- Hormonal Level Testing
- Genetic Testing
- Others (Laparoscopy)
By Treatment
- Drugs
- Surgery
- Intrauterine Insemination (IUI)
- Assisted Reproductive Technology (ART)
By End-User
- Hospitals and Clinics
- Homecare
- Pathology and Diagnostic Centers
A full report of UK Female Infertility Diagnosis and Treatment Market available @ https://www.omrglobal.com/industry-reports/uk-female-infertility-diagnosis-and-treatment-market
Company Profiles
- GlaxoSmithKline PLC
- Bayer AG
- Pfizer
- Eli Lilly & Co.
- Church & Dwight Co., Inc.
- Vitrolife
- GlaxoSmithKline Plc.
- Merck KGaA
- Esco Group
